Bank Hapoalim BM Buys New Position in Synopsys, Inc. $SNPS

Bank Hapoalim BM bought a new stake in Synopsys, Inc. (NASDAQ:SNPS - Free Report) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 4,655 shares of the semiconductor company's stock, valued at approximately $2,076,000.

Several other hedge funds also recently modified their holdings of SNPS. China Universal Asset Management Co. Ltd. increased its holdings in shares of Synopsys by 31.8% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 14,810 shares of the semiconductor company's stock worth $6,957,000 after buying an additional 3,575 shares during the last quarter. Norges Bank acquired a new position in Synopsys in the fourth quarter valued at $730,197,000. SBI Okasan Asset Management Co.Ltd. acquired a new position in Synopsys in the fourth quarter valued at $1,699,000. Mizuho Markets Americas LLC purchased a new stake in Synopsys during the first quarter valued at about $20,182,000. Finally, Atreides Management LP acquired a new stake in Synopsys during the first quarter worth about $54,288,000. 85.47% of the stock is owned by institutional investors and hedge funds.

Synopsys Stock Performance

Synopsys stock opened at $421.50 on Friday. The firm has a market capitalization of $80.71 billion, a PE ratio of 97.57, a price-to-earnings-growth ratio of 2.48 and a beta of 1.23. Synopsys, Inc. has a one year low of $366.00 and a one year high of $626.24. The stock's 50 day moving average price is $425.63 and its 200 day moving average price is $443.35. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.32 and a current ratio of 1.43.

Synopsys (NASDAQ:SNPS - Get Free Report) last issued its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.15 by $0.20. The company had revenue of $2.28 billion during the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. Synopsys's revenue for the quarter was up 41.9% on a year-over-year basis. During the same quarter last year, the company earned $3.67 earnings per share. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, sell-side analysts expect that Synopsys, Inc. will post 10.65 EPS for the current fiscal year.

Insiders Place Their Bets

In other Synopsys news, CFO Shelagh Glaser sold 3,394 shares of the business's stock in a transaction on Friday, June 12th. The shares were sold at an average price of $450.02, for a total value of $1,527,367.88. Following the transaction, the chief financial officer owned 14,358 shares in the company, valued at $6,461,387.16. The trade was a 19.12% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the company's stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the completion of the transaction, the chief executive officer directly owned 75,020 shares of the company's stock, valued at approximately $34,431,179.20. The trade was a 16.29% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is currently owned by company insiders.

Key Headlines Impacting Synopsys

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: A discounted-cash-flow analysis suggests Synopsys may be undervalued by approximately 26%, offering potential upside if the company converts strong AI and semiconductor-design demand into sustained cash-flow growth. Synopsys Stock May Be Cheap As Shares Fell 33%
• Positive Sentiment: Analysts and market commentators point to 42% revenue growth, raised guidance and Synopsys’ completed $35 billion acquisition as catalysts that could eventually support a recovery toward substantially higher price levels. These forecasts are speculative and depend on successful integration and continued AI-silicon spending. Prediction: Synopsys Will Hit $650 on This Date

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the company. Wells Fargo & Company cut their price objective on Synopsys from $535.00 to $450.00 and set an "equal weight" rating on the stock in a report on Tuesday, August 11th. Benchmark initiated coverage on Synopsys in a report on Wednesday, July 15th. They set a "buy" rating and a $570.00 target price for the company. Berenberg Bank set a $633.00 price target on shares of Synopsys in a report on Wednesday, May 27th. Morgan Stanley lifted their price target on shares of Synopsys from $480.00 to $525.00 and gave the company an "equal weight" rating in a research report on Thursday, May 28th. Finally, Zacks Research upgraded shares of Synopsys from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, June 30th. Two equities research analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Synopsys presently has a consensus rating of "Moderate Buy" and an average price target of $565.06.

Synopsys Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source